Desvenlafaxine

Study	Country Study period Study design	Data source	Exposure definition	Non-exposure definition	Exposition period	Sample size (exposed/unexposed) Or (case / control)	Remarks	Risk of bias
Marks 2021	USA 2010 - 2019 retrospective cohort	Electronic medical records (EMRs) through the Regenstrief Institute in Indianapolis, USA.	Pregnant women with one (or more) prescription of Desvenlafaxine written during the time period studied. (This is a subgroup of exposure among the whole exposed group considered in the study).	exposed to other treatment, sick Pregnant women with one (or more) prescription of Bupropion written during the time period studied.	during pregnancy (anytime or not specified)	16 / 406	'252 women (6.8%) prescribed >1 antidepressant'=> considered as monotherapy.
Marks 2021	USA 2010 - 2019 retrospective cohort		Data were obtained from electronic medical records (EMRs) through the Regenstrief Institute in Indianapolis.		during pregnancy (anytime or not specified)	16 / 406

Study	Country Study period Study design	Data source	Case	Control	Exposition	Exposition period	Sample size (exposed/unexposed) Or (case / control)	Remarks	Risk of bias
Anderson 2020	USA 1997 - 2011 case control	The National Birth Defects Prevention Study (NBDPS), a US population-based, multisite case-control study.	The case infants were infants born alive or died at 20 SG or more and who had received a diagnosis of at least one selected birth defect.	The controls were live-born infants with no major birth defects who were randomly selected from hospital or state birth-certificate records from the same geographic areas.	Information on exposure to SSRIs and other potential risk factors during pregnancy were collected by standardized telephone interviews with mothers of case and control infants, conducted 6 weeks to 24 months after the EDD.	1st trimester	30630 / 11478	'Infants with recognized or strongly suspected chromosomal abnormalities or single-gene conditions were excluded from the study.'
Anderson 2020	USA 1997 - 2011 case control		Case infants were ascertained through population-based birth-defects surveillance systems in 10 U.S. states. Controls were selected randomly from the same geographic areas. Clinical data were abstracted from medical records and classified by clinician geneticists and other clinicians.			1st trimester	30630 / 11478

Risk of bias: : NA; : low; : moderate; : serious; : critical; : unclear;